| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
18,870 |
16,649 |
$777K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,210 |
4,669 |
$315K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
8,776 |
8,455 |
$305K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,151 |
4,015 |
$235K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,264 |
4,067 |
$217K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,752 |
1,710 |
$99K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,911 |
3,814 |
$30K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
206 |
184 |
$29K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,051 |
1,944 |
$24K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
282 |
275 |
$18K |
| 99381 |
|
239 |
224 |
$15K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
573 |
541 |
$15K |
| D1208 |
Topical application of fluoride, excluding varnish |
673 |
658 |
$10K |
| 36415 |
Collection of venous blood by venipuncture |
3,554 |
3,259 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
641 |
336 |
$8K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
115 |
112 |
$5K |
| 99188 |
|
205 |
186 |
$4K |
| 85013 |
|
878 |
850 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
380 |
342 |
$3K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
48 |
47 |
$3K |
| 90670 |
|
2,349 |
2,257 |
$2K |
| 85018 |
|
997 |
966 |
$2K |
| 90686 |
|
1,186 |
1,169 |
$1K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
48 |
47 |
$1K |
| 90698 |
|
2,315 |
2,220 |
$1K |
| 99349 |
|
16 |
12 |
$1K |
| 90633 |
|
1,635 |
1,584 |
$1K |
| 99177 |
|
86 |
85 |
$885.10 |
| 87486 |
|
48 |
47 |
$813.18 |
| 87581 |
|
48 |
47 |
$813.18 |
| 90671 |
|
191 |
172 |
$803.79 |
| 99174 |
|
69 |
58 |
$391.24 |
| 90716 |
|
918 |
886 |
$318.39 |
| 90744 |
|
1,058 |
1,014 |
$292.00 |
| 90700 |
|
1,297 |
1,246 |
$233.50 |
| 85014 |
|
110 |
107 |
$232.37 |
| 90707 |
|
946 |
911 |
$189.32 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
12 |
12 |
$156.42 |
| 90734 |
|
68 |
68 |
$115.88 |
| 90680 |
|
1,456 |
1,397 |
$115.50 |
| 90685 |
|
230 |
222 |
$72.96 |
| 81002 |
|
25 |
25 |
$63.65 |
| 94760 |
|
586 |
511 |
$4.20 |
| 90677 |
|
67 |
67 |
$0.00 |
| 90651 |
|
25 |
25 |
$0.00 |
| 90648 |
|
281 |
274 |
$0.00 |
| 90713 |
|
91 |
91 |
$0.00 |
| 90715 |
|
25 |
25 |
$0.00 |